Rhumbline Advisers Taro Pharmaceutical Industries LTD Call Options Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TARO
# of Institutions
9Shares Held
17KCall Options Held
0Put Options Held
0-
Credit Suisse Ag Zurich, V813.1KShares$00.0% of portfolio
-
Lri Investments, LLC Palm Beach Gardens, FL2KShares$00.0% of portfolio
-
Covington Capital Management750Shares$00.0% of portfolio
-
Wipfli Financial Advisors Llc,711Shares$00.0% of portfolio
-
Lindbrook Capital, LLC142Shares$00.0% of portfolio
About TARO PHARMACEUTICAL INDUSTRIES LTD
- Ticker TARO
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 37,584,600
- Description
- Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...